Published on in Vol 28 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/76204, first published .
Therapeutic Effects of a WeChat Mini-Program on Metabolic Dysfunction–Associated Fatty Liver Disease: Randomized Controlled Trial

Therapeutic Effects of a WeChat Mini-Program on Metabolic Dysfunction–Associated Fatty Liver Disease: Randomized Controlled Trial

Therapeutic Effects of a WeChat Mini-Program on Metabolic Dysfunction–Associated Fatty Liver Disease: Randomized Controlled Trial

Chao Sun   1 , MD, PhD ;   Guangyu Chen   2 , MD, PhD ;   Cuicui Shi   1 , MD, PhD ;   Haixia Cao   1 , MD, PhD ;   Ruixu Yang   1 , MD, PhD ;   Jing Zeng   1 , MD, PhD ;   Xiaoyan Duan   1 , MD, PhD ;   Xin Sun   2 , MD ;   Jian-Gao Fan   1 , MD, PhD

1 Center for Fatty Liver Disease, Department of Gastroenterology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

2 Clinical Research and Innovation Unit, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Corresponding Author:

  • Jian-Gao Fan, MD, PhD
  • Center for Fatty Liver Disease, Department of Gastroenterology
  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
  • 1665 Kong Jiang Road
  • Shanghai 200092
  • China
  • Phone: 86 02125077340
  • Email: fanjiangao@xinhuamed.com.cn